Bydureon is a brand of injectable drug that is prescribed for patients with Type 2 diabetes. Â Type 2 diabetes is considered the most common type of diabetes that is characterized by high sugar levels secondary to a metabolic disorder that results to low insulin. Â Insulin is important in terms of blood sugar regulation but when this hormone is relatively absent, patients will develop diabetes. Â Typical symptoms of Type 2 diabetes include frequent thirst, frequent urination, increased urge to eat, and possible weight loss. Â As the disease progresses, patients may have problems with their nerves and vision. Â Some people will also easily get tired while others will have concerns regarding their blood pressure. Â With Bydureon injection, patients diagnosed with Type 2 diabetes may get some relief with just a single shot for an entire week.
At a frequency of only once a week, Bydureon injections have been proven to effectively regulate sugar levels in the blood of patients with Type 2 diabetes. Through the active ingredient exenatide, the pancreas will be stimulated to produce more insulin which helps in the maintenance of healthy blood sugar levels. Â The main formulation of Bydureon involves an extended release mechanism of exenatide and this makes the injection work for about 1 week. Â This drug is accepted as good news for Type 2 diabetes sufferers because most treatments involve daily or regular injections. Â With Bydureon, Type 2 diabetes can be managed with weekly shots only.
As with any other medication or treatment program, the use of Bydureon comes along with advice regarding proper diet and exercise to help patients maintain healthy blood sugar levels. Â As doctors would always point out, diabetes can best be managed if patients also try to have an active lifestyle and eat healthy foods. Â As with any other drug, there are also side effects to Bydureon injections and treatment. Â The greatest concern is the drug’s possible stimulation of certain cancers like those of the thyroid gland. Â There are studies that link this drug to some cardiovascular diseases.